How to choose your perfect CMO partner

What do Pharma and Biotech look for when selecting their CMO partner? The development of a new vaccine is a complex venture. Biotech and pharmaceutical companies are increasingly choosing to outsource their manufacturing efforts, as partnering with the right CMO can streamline this process. Since 2011, total global spending on contract manufacturing reached $31.9 billion according to a 2012 industry …

This is the Future of the Vaccine Industry

  The vaccine business is changing. The vaccine industry is moving at a remarkable pace. And we here at Vaccine Nation have sought out the the leading minds within the vaccines industry to explain the challenges and opportunities we can expect in the future. Our experts from across the vaccines spectrum explain to us the mechanics behind the vaccine industry …

NanoViricides Partners with Viroclinics Biosciences

February 4th, 2014 NanoViricides, Inc. reported today that it has signed a “confidential disclosure agreement” (“CDA”) with Viroclinics Biosciences, BV (“Viroclinics”), a spinoff of the Department of Viroscience at the Erasmus Medical Centre (“Erasmus”) in Rotterdam, the Netherlands. The agreement will allow the scientists at Viroclinics to develop a specific proposal for the testing of different nanoviricides , such as …

Partnering to Deliver Vaccines

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by George Adams and Christophe Coutourier from EMD MIllipore, entitled: ‘Partnering to Deliver Vaccines' This presentation outlines: …

Rethinking Engagement and Involvement of Partners to improve Trust and Uptake

Tine Rikke Jørgensen, Head of Dept, Global Market Access and Pricing, Lundbeck A/S joined us at the World Vaccine Congress Lyon 2012 to give details on rethinking engagement and involvement of partners to improve trust and uptake. Key messages from this presentation were: Vaccines are public health and public health is politics … Identify common objectives with stakeholders The majority …

Building Global Momentum for vaccines- Peg Willingham

  Watch the video here Subscribe: http://www.youtube.com/user/vaccinenation  Building global momentum for vaccines Corporate strategy is important to fostering a public understanding about vaccine, and therefore helping to improve public perception. Peg Willingham, Executive Director, Global Vaccines Campaign, United Nations Foundation, presented at the World Vaccine Congress in Washington about the importance of building a global momentum for vaccines as one …

Collaborations and co-development- John Trizzino

Watch the video here!   Subscribe: http://www.youtube.com/user/vaccinenation  An exclusive license to develop and sell flu vaccines using it’s technology has just been given to pharmaceutical company LG Life Sciences Ltd by Novavax. Inc., for use in South Korea. LG also receives a non-exclusive license to make and sell flu vaccines in certain emerging markets. LG will be responsible for funding …

Partnering: Success in the 21st Century

Partnering: Success in the 21st Century Dr Allan Jarvis, VP Corporate Development, Sanofi-Pasteur Partnering: Success in the 21st Century   Subscribe: http://www.youtube.com/user/vaccinenation  One of the more popular speakers at the Congress, Allan Jarvis of Sanofi-Pasteur, spoke on the role of partnering to accelerate growth. As a backdrop for the most recent discussion, he gave an overview of Sanofi’s strategy on …

Interview with George Adams from EMD Millipore

George Adams, Vaccine Program Manager, EMD Millipore tells us why he sponsors the World Vaccine Congress. EMD Millipore (known as Merck Millipore outside of the U.S. and Canada) is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and …